The Prognostic and Therapeutic Role of Histone Acetylation Modification in LIHC Development and Progression.

Gao, Ji; Han, Sheng; Gu, Jian; Wu, Chen; Mu, Xiaoxin

Gao, Ji; Han, Sheng; Gu, Jian; Wu, Chen; Mu, Xiaoxin.

Afiliación

Gao J; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Han S; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, Nanjing 210029, China.
Gu J; NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing 210029, China.
Wu C; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Mu X; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, Nanjing 210029, China.

Medicina (Kaunas) ; 59(9)2023 Sep 18.

Article en En | MEDLINE | ID: mdl-37763801

Asunto(s)

Carcinoma Hepatocelular; Neoplasias Hepáticas; Sirtuinas; Humanos; Histonas; Acetilación; Pronóstico; Microambiente Tumoral

Palabras clave

LIHC; histone acetylation; immunotherapy; signature; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Sirtuinas / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google